Vital Therapies Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cost of Goods Sold (COGS) incl. D&A
799.00
1,087.00
1,328.00
1,808.00
998.00
Gross Income
799.00
1,087.00
1,328.00
1,808.00
998.00
SG&A Expense
30,603.00
49,255.00
49,929.00
39,458.00
51,657.00
EBIT
31,402.00
50,342.00
51,257.00
41,266.00
52,655.00
Unusual Expense
1,306.00
2,600.00
863.00
-
-
Non Operating Income/Expense
15.00
56.00
39.00
13.00
73.00
Pretax Income
32,718.00
47,667.00
52,023.00
40,969.00
52,078.00
Consolidated Net Income
31,412.00
47,667.00
52,023.00
40,969.00
52,078.00
Net Income
31,412.00
47,667.00
52,023.00
40,969.00
52,078.00
Net Income After Extraordinaries
31,412.00
47,667.00
52,023.00
40,969.00
52,078.00
Net Income Available to Common
31,412.00
56,821.00
52,023.00
40,969.00
52,078.00
EPS (Basic)
3.14
3.54
2.07
1.31
1.31
Basic Shares Outstanding
23,790.70
16,054.50
25,152.90
31,387.60
39,859.00
EPS (Diluted)
1.32
3.54
2.07
1.31
1.31
Diluted Shares Outstanding
23,790.70
16,054.50
25,152.90
31,387.60
39,859.00
EBITDA
30,603.00
49,255.00
49,929.00
39,458.00
51,657.00
Non-Operating Interest Income
5.00
19.00
58.00
284.00
650.00
Other After Tax Income (Expense)
1,306.00
-
-
-
-
Preferred Dividends
-
9,154.00
-
-
-
About Vital Therapies
View Profile
